MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on Blue Rx PDP Complete (S5593-003)

Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Pennsylvania + 1 more
Premium
$164.80/month
Deductible
$200.00, doesn't apply to tier 1 and 2
Change plan

6 of 8 Multiple sclerosis drugs are covered on this plan. All 6 require prior authorization.

2 aren't on the formulary (Mayzent and Mavenclad).

  • Kesimpta
    ofatumumab
    Covered · prior auth
    $2,410.30
    Tier 5
  • teriflunomide
    generic Aubagio
    Covered · prior auth
    from $297.98
    Tier 5
  • dimethyl fumarate
    generic Tecfidera
    Covered · prior auth
    from $74.55
    Tier 4
  • Vumerity
    diroximel fumarate
    Covered · prior auth
    $2,117.18
    Tier 5
  • fingolimod
    generic Gilenya
    Covered · prior auth
    $555.30
    Tier 5
  • Zeposia
    ozanimod
    Covered · prior auth
    from $76.97
    Tier 5
Not on the formulary
Mayzent, Mavenclad

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $200.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list